| Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science D Stephenson, R Alexander, V Aggarwal, R Badawy, L Bain, R Bhatnagar, ... Digital biomarkers 4 (1), 28-49, 2020 | 43 | 2020 |
| How can natural language processing help model informed drug development?: a review R Bhatnagar, S Sardar, M Beheshti, JT Podichetty JAMIA open 5 (2), ooac043, 2022 | 24 | 2022 |
| Identifying and characterising sources of variability in digital outcome measures in Parkinson’s disease G Roussos, TR Herrero, DL Hill, AV Dowling, M LTM Müller, LJW Evers, ... NPJ Digital Medicine 5 (1), 93, 2022 | 7 | 2022 |
| Metadata framework to support deployment of digital health technologies in clinical trials in Parkinson’s disease DL Hill, D Stephenson, J Brayanov, K Claes, R Badawy, S Sardar, ... Sensors 22 (6), 2136, 2022 | 6 | 2022 |
| Approaching neural net feature interpretation using stacked autoencoders: gene expression profiling of systemic lupus erythematosus patients MK Breitenstein, VJY Hu, R Bhatnagar, M Ratnagiri AMIA Summits on Translational Science Proceedings 2019, 435, 2019 | 3 | 2019 |
| A progress update on the Critical Path for Parkinson's consortium's pre-competitive 3DT initiative M Mueller, J Cosman, J Adams, R Badawy, R Bhatnagar, B Bloem, ... MOVEMENT DISORDERS 37, S196-S196, 2022 | 1 | 2022 |
| Metadata standards to support deployment of digital health technologies in clinical trials in parkinson's disease D Hill, D Stephenson, J Brayanov, K Claes, R Badawy, S Sardar, K Fisher, ... MOVEMENT DISORDERS 36, S561-S561, 2021 | 1 | 2021 |
| DEEP LEARNING FOR PRECISION MEDICINE: STACKED AUTOENCODERS OVERCOME CLASSIFICATION IMBALANCE IN GENE EXPRESSION PROFILING OF SYSTEMIC LUPUS ERYTHEMATOSUS TREATMENTS. R Bhatnagar, VJY Hu, M Ratnagiri, MK Breitenstein CLINICAL PHARMACOLOGY & THERAPEUTICS 105, S86-S86, 2019 | 1 | 2019 |
| Unlocking the Capabilities of Large Language Models for Accelerating Drug Development W Anderson, I Braun, R Bhatnagar, K Romero, R Walls, M Schito, ... Clinical Pharmacology & Therapeutics, 2024 | | 2024 |
| UNLOCKING HIDDEN DRUG-REPURPOSING OPPORTUNITIES: NLP-POWERED TOPIC MODELING OF UNSTRUCTURED CURE-ID DATA Roopal Bhatnagar, Wes Anderson, Jagdeep Podichetty, Ramona Walls, Marco Schito American Society of Clinical Pharmacology and Therapeutics Annual Meeting …, 2024 | | 2024 |
| Interaction with Regulatory Agencies Worldwide to Advance the Use of Digital Health Technology in Parkinson's Disease Clinical Research: the Critical Path for Parkinson's Pre … M Mueller, J Cosman, JL Adams, R Badawy, R Bhatnagar, B Bloem, ... MOVEMENT DISORDERS 37, S21-S22, 2022 | | 2022 |
| A metadata-driven tool to determine the robustness of digital health technologies assessments for Parkinson’s disease leveraging the voice of the patient S Sardar, R Bhatnagar, R Badawy, J Burton, V Aggarwal, K Romero, ... MOVEMENT DISORDERS 36, S573-S573, 2021 | | 2021 |
| Identifying and Controlling Variability in Digital Health Measures in Parkinson’s disease Clinical Trials G Roussos, R Bhatnagar, J Burton, J Cosman, A Derungs, AV Dowling, ... MOVEMENT DISORDERS 36, S150-S150, 2021 | | 2021 |
